SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
+23.23%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$3.11M
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
313
Increased
959
Reduced
613
Closed
175
Top Buys
| 1 |
Golub Capital BDC
GBDC
|
+$77.5M |
| 2 |
Keysight
KEYS
|
+$53.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$46.8M |
| 4 |
AbbVie
ABBV
|
+$43M |
| 5 |
Merck
MRK
|
+$40.1M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
TransDigm Group
TDG
|
+$50.5M |
| 3 |
Stryker
SYK
|
+$42.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$41M |
| 5 |
Trane Technologies
TT
|
+$40.3M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
SpartanNash
SPTN
$900M
| $711K | ﹤0.01% |
33,500
-7,600
| -18% | -$161K |
|
|
WIRE
1077
DELISTED
Encore Wire Corp
WIRE
| $707K | ﹤0.01% |
14,500
+1,200
| +9% | +$58.5K |
|
|
RAD
1078
DELISTED
Rite Aid Corporation
RAD
| $707K | ﹤0.01% |
+41,500
| New | +$707K |
|
|
CCXI
1079
DELISTED
ChemoCentryx, Inc.
CCXI
| $707K | ﹤0.01% |
12,300
+12,000
| +4,000% | +$690K |
|
1080
ePlus
PLUS
$1.93B
| $706K | ﹤0.01% |
20,000
| – | – |
|
1081
JELD-WEN Holding
JELD
$537M
| $704K | ﹤0.01% |
43,700
+3,600
| +9% | +$58K |
|
1082
Delek US
DK
$1.79B
| $703K | ﹤0.01% |
40,400
-1,200
| -3% | -$20.9K |
|
|
MODV
1083
DELISTED
ModivCare
MODV
| $702K | ﹤0.01% |
8,900
-500
| -5% | -$39.4K |
|
1084
Safety Insurance
SAFT
$1.09B
| $701K | ﹤0.01% |
9,200
+800
| +10% | +$61K |
|
1085
Novavax
NVAX
$1.34B
| $700K | ﹤0.01% |
+8,400
| New | +$700K |
|
1086
DNOW Inc
DNOW
$1.61B
| $696K | ﹤0.01% |
80,700
+5,200
| +7% | +$44.8K |
|
1087
Dynatrace
DT
$14.4B
| $694K | ﹤0.01% |
+17,114
| New | +$694K |
|
1088
Axcelis
ACLS
$2.62B
| $693K | ﹤0.01% |
+24,900
| New | +$693K |
|
1089
Primoris Services
PRIM
$6.63B
| $692K | ﹤0.01% |
39,000
+3,900
| +11% | +$69.2K |
|
1090
MillerKnoll
MLKN
$1.44B
| $687K | ﹤0.01% |
29,100
+2,400
| +9% | +$56.7K |
|
1091
Ultra Clean Holdings
UCTT
$1.12B
| $687K | ﹤0.01% |
30,400
-2,000
| -6% | -$45.2K |
|
1092
Strategy Inc Common Stock Class A
MSTR
$92.4B
| $686K | ﹤0.01% |
58,000
+5,000
| +9% | +$59.1K |
|
|
RESI
1093
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $684K | ﹤0.01% |
78,662
+687
| +0.9% | +$5.97K |
|
1094
Enanta Pharmaceuticals
ENTA
$178M
| $682K | ﹤0.01% |
13,600
+1,100
| +9% | +$55.2K |
|
1095
Scholastic
SCHL
$660M
| $682K | ﹤0.01% |
22,800
+1,600
| +8% | +$47.9K |
|
1096
Acadia Pharmaceuticals
ACAD
$4.02B
| $677K | ﹤0.01% |
13,968
-25,332
| -64% | -$1.23M |
|
1097
CEVA Inc
CEVA
$549M
| $677K | ﹤0.01% |
18,100
-2,900
| -14% | -$108K |
|
1098
Clean Harbors
CLH
$12.6B
| $675K | ﹤0.01% |
11,256
-280
| -2% | -$16.8K |
|
1099
Arvinas
ARVN
$575M
| $674K | ﹤0.01% |
20,100
+5,400
| +37% | +$181K |
|
1100
Ultragenyx Pharmaceutical
RARE
$3.01B
| $672K | ﹤0.01% |
8,600
+4,200
| +95% | +$328K |
|